TITLE

Tips for using devices off label

PUB. DATE
November 2009
SOURCE
Same-Day Surgery;Nov2009, Vol. 33 Issue 11, p111
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers several tips on the off-label use of medical devices in outpatient surgery centers and hospitals.
ACCESSION #
44596072

 

Related Articles

  • The surgeon and medical devices: adverse incident reporting and off-label use.  // British Dental Journal;8/24/2013, Vol. 215 Issue 4, p173 

    There is an ethical obligation to share off-label use with patients and this should be documented in the clinical notes, although there is no requirement to inform the Medicines and Healthcare products Regulatory Agency (MHRA).

  • FDA Issues a Final Guidance on "Good Reprint Practices.".  // Venulex Legal Summaries;2009 Q1, Special section p1 

    The article focuses on final guidelines on good reprint practices for drug and medical device makers issued by the U.S. Food and Drug Administration (FDA). It notes that the Reprint Guidance has been issued to address the lack of guidance concerning the dissemination of off-label information...

  • FDA Guidance on Off-Label Promotion and the State of the Literature From Sponsors. Psaty, Bruce M.; Ray, Wayne // JAMA: Journal of the American Medical Association;4/23/2008, Vol. 299 Issue 16, p1949 

    The author comments on proposed changes in relation to U.S. Food and Drug Administration (FDA) policy regarding sponsor-distributed literature promoting unapproved or "off-label" uses medications and medical devices. The specific requirements of the proposed FDA guidelines enabling publication...

  • Staying on Track When Prescribing Off-Label. FITZGERALD, APRIL S.; O'MALLEY, PATRICK G. // American Family Physician;1/1/2014, Vol. 89 Issue 1, p4 

    The article considers the ethics surrounding the practice of using medications or medical devices not officially approved by the U.S. Food and Drug Administration (FDA), commonly called off-label use. It discusses the legality of off-label prescribing and the reasons why it occurs, including...

  • TOP OF THE NEWS.  // Nonwovens Industry;Jun2010, Vol. 41 Issue 6, p12 

    The article offers news briefs related medical devices. The U.S. Food and Drug Administration (FDA) accused St. Jude Medical Inc. of alleged violation in the federal Food, Drug and Cosmetic Act due to off-label marketing of its Epicor surgical ablation devices. Zimmer Holdings Inc. opens a...

  • US Food and Drug Administration-Approved Laboratory Tests After Caronia. Allen, Timothy Craig // Archives of Pathology & Laboratory Medicine;Nov2013, Vol. 137 Issue 11, p1543 

    The article discusses the opinion issued by the U.S. Court of Appeals or the Second Circuit in United States versus Caronia, focusing on its implications on approved laboratory tests of the U.S. Food and Drug Administration (FDA). It states that the case directly deals with the off-label issue,...

  • take two kickbacks... Stone, Peter // Mother Jones;Nov/Dec2009, Vol. 34 Issue 6, p18 

    The article focuses on incentives provided by makers of medical implants, such as Medtronic, to physicians and surgeons to urge the use of their products. Medtronic has also been accused of defrauding Medicare and promoting Infuse, a bone-growth stimulating protein, for off-label uses. Cases...

  • Speak Out. Wright, David; Avallone, Anthony N.; Berger, Aaron; Wrenn, John // Urology Times;4/1/2009, Vol. 37 Issue 4, p30 

    The article presents answers to a question on whether pharmaceutical companies be allowed to market pharmaceutical products for off-label use.

  • Off-Label Drug Uses. . Generali, Joyce A.; Cada, Dennis J. // Hospital Pharmacy;Mar2010, Vol. 45 Issue 3, p208 

    This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This...

  • SLEEPING PILLS. Hanau, Michael S. // Primary Psychiatry;May2008, Vol. 15 Issue 5, p23 

    A letter to the editor is presented in response to an article by Milton K. Erman which critiques the popularity of trazodone and other non-benzodiazepine analogs for off-label use.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics